< PreviousZIKA EXPOSÉ10Pharma Business International www.pbiforum.net;B75:?>2C@8BC?>:?7B>:BC<3C4;B>A@A9C?>3B:@?<>=.0CA@C9BA=@CC4B;C:B>@,C*8BC;B=BA;:8B;==@;B==C@8A@C@8BC;B=59@=C7B4B>7C<>C@8B:<5>@;0&=4B:?3?:C(?+ACA@@A:+C;A@B,C*8BC?>><1A@?<>C=4A:BC3<;C6A9A;?AC?=9?+B-?=BCAC3B;@?9BC2;<5>7,CA9A;?AC;B6A?>=CA6A"<;C:<>:B;>/C-?@8CA>CB=@?6A@B7C$$C6?99?<>:A=B=C?>C$'CA9<>B,C*8BC<;97CBA9@8:A;B;2A>?=A@?<>CB=@?6A@B=C@8A@CA96<=@C8A93C@8B-<;97#=C4<459A@?<>C?=CA@C;?=+C3;<6C6A9A;?A, <;@5>A@B90/C6<;@A9?@0C;A@B=CA;BC3A99?>229<.A990,C!?>:BC$''/C;A@B=C8A1BC;B75:B7C.0$C4B;C:B>@CA6<>2CA99CA2BC2;<54=,CB:B>@90/C@8BC %)C3A=@C@;A:+B7*A3B><5?>B/C'C%B2;BB=C8A;6A:B5@?:A9#=@;BA@6B>@C3<;C4;B1B>@?>2C6A9A;?AC?>CA759@=/=4B:?3?:A990C3<;CA759@=C@;A1B99?>2C@<CA;BA=-8B;BC@8BC7?=BA=BC?=C4;B1A9B>@,CA9A;?AC:A=B=A6<>2C@;A1B99B;=C;B@5;>?>2C@<C@8BC!C8A1B.BB>C;?=?>2/C-?@8C C4B;C:B>@C<3C@8<=B?>3B:@B7C>BB7?>2C8<=4?@A9?=A@?<>,C)=C-B99CA=C;B259A@<;0CA44;<1A9=/C?>><1A@?1B:<64A>?B=CA;BCA9=<C=B:5;?>2C35>7?>2CA>72;A>@=C@<C7B1B9<4C4<@B>@?A990C2A6BC:8A>2?>26A9A;?AC@;BA@6B>@=,C>BC=5:8C:<64A>0C?=@8BC.?<48A;6AC5;BA:C-8<C@8?=C0BA;=B:5;B7C@-<C2;A>@=C3;<6C@8BCA@B= <5>7A@?<>,C*8BC35>7?>2C-?99C.BC5=B7C@<9B1B;A2BC@8BC:<64A>0#=C):@?1B4;<4809A:@?:C1A::?>BC@B:8><9<20C@<C7B1B9<46)&.A=B7C1A::?>B=C7B=?2>B7C@<C4;B1B>@?>395B>ACA>7C6A9A;?AC?>3B:@?<>,<;+?>2CA9<>2=?7BC@8BCA@B=C <5>7A@?<>/5;BA:CA?6=C@<C7B1B9<4CA>C6)&.A=B71A::?>BC@A;2B@?>2C9A=6<7?56C3A9:?4A;566A9A;?AC4A;A=?@B=/C<>BC6A9A;?AC4A;A=?@BC@8A@4<=B=C@8BC2;BA@B=@C@8;BA@C@<C856A>=,)=C-?@8C@8BCA.<1B/C%B>25BC?=CAC=?2>?3?:A>@@8;BA@C@<C856A>C8BA9@8C-?@8C=<6BC'C4B;C:B>@<3C@8BC-<;97#=C4<459A@?<>CA@C;?=+C3;<6?>3B:@?<>,C*<C7A@B/C@8B;BC?=C><C=4B:?3?:@8B;A4B5@?:=C3<;C%B>25B/C-?@8C4;B1B>@?<>9?6?@B7C@<C1B:@<;C:<>@;<9C6BA=5;B=,CB=BA;:8?=C?>=@BA7C:5;;B>@90C3<:5==B7C<>5>7B;=@A>7?>2C8<-C@8BC%B>25BC1?;5=C:A5=B=7?=BA=B=,C5@CAC1A::?>BC;B6A?>=CB95=?1B,C*8<528C3A;C3;<6C@8BC<>90C6<=5?@<&.<;>B7?=BA=B=/C(?+A/CA9A;?ACA>7C%B>25BCA;BA6<>2C@8BC6<=@C7BA790CA>7C4B;1A=?1B,*8<528C?>><1A@?<>C?=C;?4B/C@8B;BC?=>#@C0B@CA:<66B;:?A990CA1A?9A.9BC1A::?>BC3<;CB?@8B;CA>76<;@A9?@0C;A@B=/CB=4B:?A990C3<;CA9A;?A/C;B6A?>8?28,C5@C;B=BA;:8C?=C:A@:8?>2C54CA>7C-?@8C@8B=9B-C<3C>B-C7B1B9<46B>@=/C.;BA+@8;<528=A>7CA44;<1A9=/CB9?6?>A@?<>C?=C<>90CAC6A@@B;C<3@?6B,© Shutterstock / angellodec08-11_Layout 1 11/04/2018 10:40 Page 3Pharma Business International 11www.pbiforum.netZIKA EXPOSÉ© Shutterstock / Tonhom100908-11_Layout 1 11/04/2018 10:40 Page 4PROCESSING12Pharma Business International www.pbiforum.net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ppliedautomationWith access to medicines continuing to advance, and patient care improving all round,new revenue streams are being made available to the market year on year. As withalmost every other industry reliant on complex manufacturing, automated technology ishaving a transformative effect for the pharmaceutical sector.14 Á12-15_Layout 1 11/04/2018 10:42 Page 1© Shutterstock / akank12-15_Layout 1 11/04/2018 10:42 Page 2PROCESSING14Pharma Business International www.pbiforum.net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© Shutterstock / Nikolaj Kondratenko12-15_Layout 1 11/04/2018 10:42 Page 3© Shutterstock / Gunpanat© Shutterstock / Nikolaj Kondratenko12-15_Layout 1 11/04/2018 10:42 Page 4TEMPERATURE CONTROL16Pharma Business International www.pbiforum.net$.)/*-/%+".'/-+/!*'-(*#-*+)/%.)-(.'/$*%$/&,,/./(+&./*)/-$./'#&/%$,*)/-+,(!'/-$./(.-,*&",(.-/-$./%+'-'/+/-.".(,-#(./%+)-(+&/''-."'%,)/#*%&/'%,&./+#-/+/%+)-(+&/$.(.+(./*-'*"+(-,)-/,-/,&&/-*".'/-+/+%#'/+)/".-$+!'/+.*%*.)-&/",*)-,*)*) /-.".(,-#(./&..&'/*-$/,'&*--&./,"*.)-/&+''/+/-.".(,-#(./,'/+''*&./--$./.)!/+/-$./!,/*-'/,(/"+(./..)'*./-+/..,*(/%++&/-$.)/*-/*'/-+/,("/*-/#/++('/,)!/&+,!*) /,'/%(.,-./,)/*"".!*,-./#-).%.'',(/(.,%$/*)/,/,(.$+#'.'/!..)%.',&&+*) /-$./%++&.(/,*(/*)'*!./-+/.'%,./*,%+).%-*+)/%#((.)-'/$,-'/"+(./-$*'/*'/,)*).'%,,&./%+)'.#.)%./,'/-$./#&-*",-./ +,&/+-$.'./,%*&*-*.'/*'/-+/'-+(./,)!/'$*/+#-/ ++!'/,'#*%&/,'/+''*&./-+/-$.*(/*),&/!.'-*),-*+)/''#%$/$*&./*-/"* $-/./(.'#&-/*)/.).( /',*) '/-+*)'-,&&/,/)#".(/+/!++('/.-..)/-$./%+&!/'-+(, .,%*&*-/,)!/-$./&+,!*) /,'/$*'/+)&/'&+'/!+)-$./(+!#%-**-/+/-$./+(.('/*-$*)/,)!/$+'++)/-$./%,)/$,./-$./'-+%/'$*.!/+#-/&-*",-.&/*-/.%+".'/,/!**%#&-/,&,)%./.-..).).( /',*) '/,)!/-$(+# $#-/$.(.*)/-$./*),&+%#'/"#'-/,&,'/./+)/-$./.*%*.)%/+/,!*'-(*#-*+)/%.)-(./,-/*-'/%.)-(,&/ +,&//-$./'-+(, .,)!/!*'-(*#-*+)/+/ ++!'/).( /',*) '/"#'-%+"./'.%+)!/-+/-$*'/-$+# $/'$+#&!/'-*&&/.#('#.!/,-/..(/++(-#)*-/*(/%#(-,*)'/(+*!./,/+-.)-*,&/'+&#-*+)/-+/-$*'(+&."/+(/,-/-$./.(/&.,'-/"*)*"*'./-$./&+''/+$.,-/,-/&+,!*) /,'//%+&!/'-+(./,*(/%#(-,*)/+('/%(.,-*) /,/%#(-,*)/+/,*(/-$,-/%#-'/-$(+# $%#((.)-'/%(.,-*) /,/,((*.(/.-..)/-$./.-.(),&,"*.)-/,*(/,)!/-$./%$*&&.!/-.".(,-#(./*-$*)/,%+&!/'-+(./$./ (.,-.'-/.).*-/+/-$.'./''-."'/*')+-/#'-/-$./,*&*-/+(/-$./,*(/%#(-,*)/-+/"*)*"*'..).( /&+''/-$(+# $/-.".(,-#(./%+)-,"*),-*+)/#-,&'+/-+/,&&+/%+)-*)#,&/,%%.''/+(/,)/+(.('$.(./*'/)+/!++(/-+/./+.).!/+(/%&+'.!/,)!/-$.%#(-,*)/*'/',./+(/+(.('/-+/-(,.&/-$(+# $/,'/-$.!.&*.(/,)!/(."+./,&&.-*'.!/ ++!'/+-/+)&/!+.'-$*'/*"(+./ .).(,&/.*%*.)%/*-$*)/-$./%+&!/'-+(.#-/*-/,&'+/.),&.'/(++"'/-+/./.-/,-/,(*) -.".(,-#(.'//*"+(-,)-/$.)/,/,%*&*-/"* $-/$,.-+/%,-.(/+(/,/*!./(,) ./+/$,(",/(+!#%-'/-$,-(.#*(./!*.(.)-/(.(* .(,-.!/-.".(,-#(./&..&'/ /%+#('./-$.(./*'/"+(./-+/.*%*.)-&/(#))*) /,-.".(,-#(./%+)-(+&&.!/'-+(, ./,%*&*-/-$,)&# *) /#/-$./.)-(,)%.'/ ,), *) /'-+%/*-$*)-$./!*'-(*#-*+)/%.)-(./%,)/.%+"./*)%(.,'*) &"+(./%+"&./,'/-$./-.".(,-#(.'/,(./.-/&+.(+(/*)'-,)%./",%$*).(/,)!/''-."'/-$,-/(.&/+),--.(/+.(/%,)/%+"./#)!.(/(*'/,'/%+)-*)#.!.+'#(./-+/-$./%+&!/$,'/,/). ,-*./*",%-/+),--.(*.'//-*%,&&/(.'#&-*) /*)//.(/%.)-!. (,!,-*+)/-+/,--.(/&*./$*'/%,)/.%+"./,/&,( .(%+)%.()/*-$/-$./(.%.)-/"+./-+,(!'/.&.%-(*%/&*--(#%'/,)!/+(&*-'/$*%$/%,)/'../.$*%&.'/(#))*) +#-/+/#*%./,-/*)++(-#)./"+".)-'/$.)/*-%+".'/-+/+(.('/*-$*)/-$.'./,%*&*-*.'/,'/.&&-$.(./,(./,/$+'-/+/)./%+)%.()'/,)!/(+&."'/-+./,,(./+/",)/+/$*%$/*&&/(.#*(./'+".(.".!*,&/-(,*)*) /+(/%+",)*.'/"+*) /."&+..'-+/%+&!/'-+(./,%*&*-*.'/)/-$./,+./.,"&./+.&.%-(*%/.$*%&.'/'-,/)..!/-+/./",!./,,(./-$,-,/.$*%&./$*%$/*'/",(.!/!+)/,'/$,*) /,)/.* $-$+#(/,--.(/&*./"* $-/'-(# &./-+/",), ./"+(.-$,)/+#(/+(/*./$,) *) /-$./&,.&&*) /+)/-$.'..$*%&.'/%,)/ +/,/&+) /,/-+/(..)-*) /(+&."',&-.(),-*.&/*).'-*) /*)/,--.(*.'/*-$/&,( .(+&-, .'/%,)/$.&/"*)*"*'./-$./(+&."'/$.(./,(./,&'+/%+)%.()'/-+/./-,.)/*)-+/,%%+#)-$.)/!.,&*) /*-$/$.,&-$/,)!/',.-/$*&.(+*'*+)/+/-.".(,-#(./(. #&,-*) /%&+-$*) /*'/,*(&+*+#'/-,*) /'-.'/-+/",./."&+..'/,,(./+Cold factsTemperature control is an increasingly expensive part of the pharma supply chain, but no lessnecessary for that. 18 Á16-19_Layout 1 11/04/2018 10:45 Page 1Pharma Business International 17www.pbiforum.netTEMPERATURE CONTROL© Shutterstock / ESB professional16-19_Layout 1 11/04/2018 10:45 Page 2TEMPERATURE CONTROL18Pharma Business International www.pbiforum.net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ayout 1 11/04/2018 10:45 Page 3Pharma Business International 19www.pbiforum.netTEMPERATURE CONTROL,&'+/"*)*"*'.'/-$./,(.,/+/,&&',)!/%.*&*) /-$,-/)..!/-+/./-(.,-.!-+/(..)-/$.,-/&+''/*-$/!*)!&*) '-+(, ./,%*&*-*.'/,%(+''/-$./",)/%+",)*.'/,(./.*) /+(%.!-+/!+/$,-..(/-$./%,)/-+/",.',%./%+#)-/© Shutterstock / Dmitriy Yakovlev16-19_Layout 1 11/04/2018 10:45 Page 4Next >